Status:
COMPLETED
Safety Dermatological Evaluation: Acceptability With Odontological Follow up - Cepacol Teen.
Lead Sponsor:
Sanofi
Conditions:
Hygiene
Eligibility:
All Genders
10-60 years
Phase:
PHASE3
Brief Summary
To prove the safety, in normal conditions, of the Cepacol Teen, a formulation to odontological usage.
Eligibility Criteria
Inclusion
- Integral buccal mucous (without oral pathologies);
- Normal odontological exams;
Exclusion
- Lactation or gestational risk or gestation;
- Use of Antiinflammatory or immunosuppression drugs 15 days before the study;
- Being in odontological treatment;
- Pathological or mucous disease which can interfere or active gynaecological disease which may interfere wtih study results;
- Personal history of allergic disease in the area to be treated;
- Allergic or atopic history;
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT00729599
Start Date
July 1 2008
Last Update
March 4 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanofi-aventis
São Paulo, São Paulo, Brazil